Stellus Capital shows poor earnings, weak dividend coverage, high non-accruals and limited growth with declining NAV. Learn ...

Cipher Pharmaceuticals (CPHRF) is a profitable, growing Canadian drug company focused on acquiring and marketing niche ...

Griffon Corporation shows mixed segments with revenue pressure, minor profit gains and strong valuation supporting outlook.

MasTec (MTZ) delivered record Q3 2025 results, with 21% revenue growth, strong EPS, and a robust 18-month backlog reaching ...

See Goldman Sachs large-cap stocks with biggest increases in short interest ranked by their Seeking Alpha Quant rating.

Here are Goldman's top 20 S&P 500 stocks with the least concentrated hedge fund ownership as of September 30, 2025, as ranked ...

New Fortress has liquefied natural gas operations and assets across multiple jurisdictions, including an entity based in the ...

Discover why Stone (STNE) is a Buy: attractive 9x earnings, EPS growth, buybacks, and credit expansion offer strong ...

Geospace Technologies reported disappointing fourth quarter results with gross margins deteriorating to new multi-year lows.

Explore why Prospect Capital (PSEC) trades at a deep discount, its dividend risks, and what investors should know before ...

DSM seems like a high quality value play for investors with some patience. The sale of this ANH division this quarter could ...

Q3 revenue of $68 million and adjusted EBITDA of $11.2 million were well above the high end of the company’s prior guidance, ...